World Health Organization site
Skip Navigation Links
Home
Advanced Search
List ByExpand List By
Search Tips
UTNExpand UTN
ICTRP websiteExpand ICTRP website
Contact us
                   16822 records for 3277 trials found!
Trials are sometimes recorded in more than one registry. These records can refer to each other using the 'Secondary ID' field. The search portal uses these Secondary IDs to group records about the same trial together in the search results.
Each group of records referring to a trial is displayed in table that is seen by pressing the + symbol. The record with the earliest date of registration is always shown first.
 
 
 
 
  Showrecords per page     

1 2 3 4 5 6 7 8 9 10 Last
Recruitment statusProspective RegistrationMain ID Public TitleDate of Registration
RecruitingYesPER-050-16
A PHASE 2B, MULTIDOSE, MULTICENTER, DOUBLE-BLIND, PLACEBOCONTROLLED, 24 WEEK STUDY TO EVALUATE THE EFFICACY AND SAFETY OF INTRAVENOUS INFUSION WITH RECOMBINANT HUMAN SOLUBLE FC-GAMMA IIB RECEPTOR SM101 IN SUBJECTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
07/06/2017
RecruitingYesNCT03174561
Inuline Supplement in Patients With Irritable Bowel Syndrome
31/05/2017
Not recruitingYesNCT03158285
A Study Evaluating the Efficacy and Safety of Guselkumab Administered Subcutaneously in Participants With Active Psoriatic Arthritis
16/05/2017
Not recruitingYesNCT03155997
A Study to Compare Treatment After Surgery of Abemaciclib (LY2835219) Combined With Standard Endocrine Therapy Versus Endocrine Therapy Alone in Participants With Breast Cancer
15/05/2017
AuthorisedYesEUCTR2016-002778-11-FI
A Randomized, Double-blind, Phase 2 Trial to investigate how safe and how efficacious Lenvatinib is at two different starting doses (18 mg vs. 14 mg QD) when it is given in Combination with Everolimus (5 mg once a day ) in patients with Renal cancer that have already had one VEGF-Targeted Treatment 11/05/2017
RecruitingYesPER-049-16
STUDY OF EFFICACY AND SAFETY OF OFATUMUMAB COMPARED TO TERIFLUNOMIDE IN PATIENTS WITH RELAPSING MULTIPLE SCLEROSIS.
10/05/2017
Not recruitingYesNCT03143153
A Study to Evaluate Efficacy in Subjects With Esophageal Cancer Treated With Nivolumab and Ipilimumab or Nivolumab Combined With Fluorouracil Plus Cisplatin Versus Fluorouracil Plus Cisplatin
Recruitment statusMain IDPublic titleDate of registration
Not RecruitingJPRN-JapicCTI-173598A phase III study of Nivolumab (CheckMate648)30/05/2017
04/05/2017
Not recruitingYesNCT03138486
A Study of the Effectiveness in Patients With Gastric or Gastroesophageal Junction Cancer With Nivolumab by Itself or in Combination With Ipilimumab and in Patients With Esophageal Cancer With Combination of Nivolumab and Ipilimumab.
01/05/2017
Not recruitingYesNCT03175341
Intravenous Ascorbic Acid Supplementation in Neoadjuvant Chemotherapy for Breast Cancer
29/04/2017
AuthorisedYesEUCTR2015-005356-99-AT
A study in people with type 1 diabetes to determine how well a meal-time insulin, LY900014, controls diabetes compared to Humalog (insulin lispro) when both are used along with a long-acting insulin.
21/04/2017
     
1 2 3 4 5 6 7 8 9 10 Last
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.3 - Version history